{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:12:22Z","timestamp":1793229142982,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rare monogenic disorders often share molecular etiologies involved in the pathogenesis of common diseases. Congenital disorders of glycosylation (CDG) and deglycosylation (CDDG) are rare pediatric disorders with symptoms that range from mild to life threatening. A biological mechanism shared among CDG and CDDG as well as more common neurodegenerative diseases such as Alzheimer\u2019s disease and amyotrophic lateral sclerosis, is endoplasmic reticulum (ER) stress. We developed isogenic human cellular models of two types of CDG and the only known CDDG to discover drugs that can alleviate ER stress. Systematic phenotyping confirmed ER stress and identified elevated autophagy among other phenotypes in each model. We screened 1049 compounds and scored their ability to correct aberrant morphology in each model using an agnostic cell-painting assay based on &gt;300 cellular features. This primary screen identified multiple compounds able to correct morphological phenotypes. Independent validation shows they also correct cellular phenotypes and alleviate each of the ER stress markers identified in each model. Many of the active compounds are associated with microtubule dynamics, which points to new therapeutic opportunities for both rare and more common disorders presenting with ER stress, such as Alzheimer\u2019s disease and amyotrophic lateral sclerosis.<\/jats:p>","DOI":"10.1038\/s41419-021-04045-4","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T02:03:04Z","timestamp":1628128984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Precision genetic cellular models identify therapies protective against ER stress"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1693-9392","authenticated-orcid":false,"given":"Irina V.","family":"Lebedeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle V.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Sahdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuli","family":"Anyanwu-Ofili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehangir S.","family":"Wadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunaretnam","family":"Rajagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5649-9603","authenticated-orcid":false,"given":"Michael J.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"4045_CR1","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1093\/hmg\/ddl060","volume":"15","author":"L Peltonen","year":"2006","unstructured":"Peltonen L, Perola M, Naukkarinen J, Palotie A. Lessons from studying monogenic disease for common disease. Hum Mol Genet. 2006;15:R67\u2013R74.","journal-title":"Hum Mol Genet."},{"key":"4045_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1474-4422(16)30359-3","volume":"16","author":"AS Allen","year":"2017","unstructured":"Allen AS, Bellows ST, Berkovic SF, Bridgers J, Burgess R, Cavalleri G, et al. Ultra-rare genetic variation in common epilepsies: a case-control sequencing study. Lancet Neurol. 2017;16:135\u201343.","journal-title":"Lancet Neurol."},{"key":"4045_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1474-4422(12)70238-7","volume":"12","author":"BD Roussel","year":"2013","unstructured":"Roussel BD, Kruppa AJ, Miranda E, Crowther DC, Lomas DA, Marciniak SJ. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol. 2013;12:105\u201318.","journal-title":"Lancet Neurol."},{"key":"4045_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnins.2017.00220","volume":"11","author":"J Jung","year":"2017","unstructured":"Jung J, Michalak M, Agellon LB. Endoplasmic reticulum malfunction in the nervous system. Front Neurosci. 2017;11:220.","journal-title":"Front Neurosci."},{"key":"4045_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrneurol.2017.99","volume":"13","author":"C Hetz","year":"2017","unstructured":"Hetz C, Saxena S. ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol. 2017;13:477\u201391.","journal-title":"Nat Rev Neurol."},{"key":"4045_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1749-6632.2010.05840.x","volume":"1214","author":"J Jaeken","year":"2010","unstructured":"Jaeken J. Congenital disorders of glycosylation. Ann N Y Acad Sci. 2010;1214:190\u20138.","journal-title":"Ann N Y Acad Sci."},{"key":"4045_CR7","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1074\/jbc.R112.429274","volume":"288","author":"HH Freeze","year":"2013","unstructured":"Freeze HH. Understanding human glycosylation disorders: biochemistry leads the charge. J Biol Chem. 2013;288:6936\u201345.","journal-title":"J Biol Chem."},{"key":"4045_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/gim.2014.22","volume":"16","author":"GM Enns","year":"2014","unstructured":"Enns GM, Shashi V, Bainbridge M, Gambello MJ, Zahir FR, Bast T, et al. Mutations in NGLY1 cause an inherited disorder of the endoplasmic reticulum-associated degradation pathway. Genet Med. 2014;16:751\u20138.","journal-title":"Genet Med"},{"key":"4045_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ng0597-88","volume":"16","author":"G Matthijs","year":"1997","unstructured":"Matthijs G, Schollen E, Pardon E, Veiga-Da-Cunha M, Jaeken J, Cassiman JJ, et al. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet. 1997;16:88\u201392.","journal-title":"Nat Genet"},{"key":"4045_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-6-52","volume":"6","author":"L Sun","year":"2013","unstructured":"Sun L, Zhao Y, Zhou K, Freeze HH, Zhang YW, Xu H. Insufficient ER-stress response causes selective mouse cerebellar granule cell degeneration resembling that seen in congenital disorders of glycosylation. Mol Brain. 2013;6:52.","journal-title":"Mol Brain"},{"key":"4045_CR11","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1021\/bi00578a008","volume":"18","author":"A Heifetz","year":"1979","unstructured":"Heifetz A, Keenan RW, Elbein AD. Mechanism of action of tunicamycin on the UDP-GlcNAc:dolichyl-phosphate Glc-NAc-1-phosphate transferase. Biochemistry. 1979;18:2186\u201392.","journal-title":"Biochemistry"},{"key":"4045_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/humu.10239","volume":"22","author":"X Wu","year":"2003","unstructured":"Wu X, Rush JS, Karaoglu D, Krasnewich D, Lubinsky MS, Waechter CJ, et al. Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) causes a novel congenital disorder of Glycosylation Type Ij. Hum Mutat. 2003;22:144\u201350.","journal-title":"Hum Mutat."},{"key":"4045_CR13","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ymgme.2012.01.001","volume":"105","author":"AE W\u00fcrde","year":"2012","unstructured":"W\u00fcrde AE, Reunert J, Rust S, Hertzberg C, Haverk\u00e4mper S, N\u00fcrnberg G, et al. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease. Mol Genet Metab. 2012;105:634\u201341.","journal-title":"Mol Genet Metab."},{"key":"4045_CR14","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1158\/0008-5472.CAN-08-0072","volume":"68","author":"IV Lebedeva","year":"2008","unstructured":"Lebedeva IV, Su ZZ, Vozhilla N, Chatman L, Sarkar D, Dent P, et al. Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7\/interleukin-24 and perillyl alcohol. Cancer Res. 2008;68:7439\u201347.","journal-title":"Cancer Res"},{"key":"4045_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1172\/JCI39678","volume":"120","author":"SG Fonseca","year":"2010","unstructured":"Fonseca SG, Ishigaki S, Oslowski CM, Lu S, Lipson KL, Ghosh R, et al. Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest. 2010;120:744\u201355.","journal-title":"J Clin Invest"},{"key":"4045_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"4045_CR17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/0014-5793(95)01357-1","volume":"377","author":"E Van Schaftingen","year":"1995","unstructured":"Van Schaftingen E, Jaeken J. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett. 1995;377:318\u201320.","journal-title":"FEBS Lett."},{"key":"4045_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/jmg.2006.044735","volume":"44","author":"JM van de Kamp","year":"2007","unstructured":"van de Kamp JM, Lefeber DJ, Ruijter GJ, Steggerda SJ, den Hollander NS, Willems SM, et al. Congenital disorder of glycosylation type Ia presenting with hydrops fetalis. J Med Genet. 2007;44:277\u201380.","journal-title":"J Med Genet"},{"key":"4045_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/adc.85.3.236","volume":"85","author":"S Kjaergaard","year":"2001","unstructured":"Kjaergaard S, Schwartz M, Skovby F. Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H\/F119L genotype. Arch Dis Child. 2001;85:236\u20139.","journal-title":"Arch Dis Child"},{"key":"4045_CR20","doi-asserted-by":"publisher","first-page":"eaal3321","DOI":"10.1126\/science.aal3321","volume":"356","author":"PJ Thul","year":"2017","unstructured":"Thul PJ, Akesson L, Wiking M, Mahdessian D, Geladaki A, Ait Blal H, et al. A subcellular map of the human proteome. Science. 2017;356:eaal3321.","journal-title":"Science"},{"key":"4045_CR21","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A. et al. A subcellular map of the human proteome. Science. 2015;347:1260419","journal-title":"Science"},{"key":"4045_CR22","first-page":"240","volume":"19","author":"MR Lecca","year":"2005","unstructured":"Lecca MR, Wagner U, Patrignani A, Berger EG, Hennet T. Genome-wide analysis of the unfolded protein response in fibroblasts from congenital disorders of glycosylation type-I patients. FASEB J. 2005;19:240\u20132.","journal-title":"FASEB J."},{"key":"4045_CR23","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1007\/s12035-016-0114-x","volume":"54","author":"V C\u00f3ppola-Segovia","year":"2017","unstructured":"C\u00f3ppola-Segovia V, Cavarsan C, Maia FG, Ferraz AC, Nakao LS, Lima MM, et al. ER stress induced by tunicamycin triggers alpha-synuclein oligomerization, dopaminergic neurons death and locomotor impairment: a new model of Parkinson\u2019s disease. Mol Neurobiol. 2017;54:5798\u2013806.","journal-title":"Mol Neurobiol."},{"key":"4045_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/B978-0-12-385928-0.00016-X","volume":"491","author":"J Shang","year":"2011","unstructured":"Shang J. Quantitative measurement of events in the mammalian unfolded protein response. Methods Enzymol. 2011;491:293\u2013308.","journal-title":"Methods Enzymol."},{"key":"4045_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1126\/science.1101902","volume":"307","author":"M Boyce","year":"2005","unstructured":"Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D, et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science. 2005;307:935\u20139.","journal-title":"Science"},{"key":"4045_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrmicro3393","volume":"13","author":"J Celli","year":"2015","unstructured":"Celli J, Tsolis RM. Bacteria, the endoplasmic reticulum and the unfolded protein response: friends or foes? Nat Rev Microbiol. 2015;13:71\u201382.","journal-title":"Nat Rev Microbiol"},{"key":"4045_CR27","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1080\/15548627.2015.1091141","volume":"11","author":"HO Rashid","year":"2015","unstructured":"Rashid HO, Yadav RK, Kim HR, Chae HJ. ER stress: Autophagy induction, inhibition and selection. Autophagy. 2015;11:1956\u201377.","journal-title":"Autophagy"},{"key":"4045_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7:R100.","journal-title":"Genome Biol."},{"key":"4045_CR29","doi-asserted-by":"publisher","first-page":"e80999","DOI":"10.1371\/journal.pone.0080999","volume":"8","author":"SM Gustafsdottir","year":"2013","unstructured":"Gustafsdottir SM, Ljosa V, Sokolnicki KL, Anthony Wilson J, Walpita D, Kemp MM, et al. Multiplex cytological profiling assay to measure diverse cellular states. PLoS ONE. 2013;8:e80999.","journal-title":"PLoS ONE"},{"key":"4045_CR30","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1021\/acs.jmedchem.6b01254","volume":"60","author":"CR Coxon","year":"2017","unstructured":"Coxon CR, Anscombe E, Harnor SJ, Martin MP, Carbain B, Golding BT, et al. Cyclin-dependent kinase (CDK) inhibitors: structure-activity relationships and insights into the CDK-2 selectivity of 6-substituted 2-arylaminopurines. J. Med Chem. 2017;60:1746\u201367.","journal-title":"J. Med Chem."},{"key":"4045_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1021\/jm1011319","volume":"54","author":"S Ioannidis","year":"2011","unstructured":"Ioannidis S, Lamb ML, Wang T, Almeida L, Block MH, Davies AM, et al. Discovery of 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a novel inhibitor of the Jak\/Stat pathway. J Med Chem. 2011;54:262\u201376.","journal-title":"J Med Chem"},{"key":"4045_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1568011023354290","volume":"2","author":"MA Jordan","year":"2002","unstructured":"Jordan MA. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr. Med Chem. Anticancer Agents. 2002;2:1\u201317.","journal-title":"Curr. Med Chem. Anticancer Agents"},{"key":"4045_CR33","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1242\/jcs.087965","volume":"124","author":"S Kadir","year":"2011","unstructured":"Kadir S, Astin JW, Tahtamouni L, Martin P, Nobes CD. Microtubule remodelling is required for the front-rear polarity switch during contact inhibition of locomotion. J. Cell Sci. 2011;124:2642\u201353.","journal-title":"J. Cell Sci."},{"key":"4045_CR34","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1523\/JNEUROSCI.16-10-03236.1996","volume":"16","author":"MW Rochlin","year":"1996","unstructured":"Rochlin MW, Wickline KM, Bridgman PC. Microtubule stability decreases axon elongation but not axoplasm production. J Neurosci. 1996;16:3236\u201346.","journal-title":"J Neurosci."},{"key":"4045_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/cm.970080207","volume":"8","author":"Z Sahenk","year":"1987","unstructured":"Sahenk Z, Brady ST. Axonal tubulin and microtubules: morphologic evidence for stable regions on axonal microtubules. Cell Motil Cytoskeleton. 1987;8:155\u201364.","journal-title":"Cell Motil Cytoskeleton"},{"key":"4045_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4161\/cib.15552","volume":"4","author":"V Sengottuvel","year":"2011","unstructured":"Sengottuvel V, Fischer D. Facilitating axon regeneration in the injured CNS by microtubules stabilization. Commun Integr Biol. 2011;4:391\u20133.","journal-title":"Commun Integr Biol."},{"key":"4045_CR37","doi-asserted-by":"publisher","first-page":"R660","DOI":"10.1016\/j.cub.2014.05.033","volume":"24","author":"PS Gurel","year":"2014","unstructured":"Gurel PS, Hatch AL, Higgs HN. Connecting the cytoskeleton to the endoplasmic reticulum and Golgi. Curr Biol. 2014;24:R660\u2013R672.","journal-title":"Curr Biol."},{"key":"4045_CR38","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1128\/MCB.00980-14","volume":"34","author":"GP Meares","year":"2014","unstructured":"Meares GP, Liu Y, Rajbhandari R, Qin H, Nozell SE, Mobley JA, et al. PERK-dependent activation of JAK1 and STAT3 contributes to endoplasmic reticulum stress-induced inflammation. Mol Cell Biol. 2014;34:3911\u201325.","journal-title":"Mol Cell Biol."},{"key":"4045_CR39","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/sj.cdd.4401108","volume":"9","author":"MD Nguyen","year":"2002","unstructured":"Nguyen MD, Mushynski WE, Julien JP. Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ. 2002;9:1294\u2013306.","journal-title":"Cell Death Differ."},{"key":"4045_CR40","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1523\/JNEUROSCI.4658-15.2016","volume":"36","author":"H Qin","year":"2016","unstructured":"Qin H, Buckley JA, Li X, Liu Y, Fox TH 3rd, Meares GP, et al. Inhibition of the JAK\/STAT pathway protects against alpha-synuclein-induced neuroinflammation and dopaminergic neurodegeneration. J. Neurosci. 2016;36:5144\u201359.","journal-title":"J. Neurosci."},{"key":"4045_CR41","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.freeradbiomed.2012.02.046","volume":"52","author":"QA Sun","year":"2012","unstructured":"Sun QA, Hess DT, Wang B, Miyagi M, Stamler JS. Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine (VAS2870). Free Radic Biol Med. 2012;52:1897\u2013902.","journal-title":"Free Radic Biol Med"},{"key":"4045_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.brainresbull.2016.06.016","volume":"126","author":"AJ Matamoros","year":"2016","unstructured":"Matamoros AJ, Baas PW. Microtubules in health and degenerative disease of the nervous system. Brain Res. Bull. 2016;126:217\u201325.","journal-title":"Brain Res. Bull."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04045-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04045-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04045-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T04:15:09Z","timestamp":1669954509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04045-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["4045"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-04045-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.03.132886","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]},"assertion":[{"value":"9 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DBG is a founder of and holds equity in Praxis, serves as a consultant to AstraZeneca, and has received research support from Janssen, Gilead, Biogen, AstraZeneca and UCB. MBH serves as a consultant to the Muscular Dystrophy Association, and receives research support from Biogen. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"770"}}